Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2025-12-24 @ 3:37 PM
NCT ID:
NCT05032092
Eligibility Criteria:
Inclusion Criteria:
* Initial diagnosis of histologically confirmed locally advanced and/or metastatic solid cancer
* Radiologically confirmed progression under the most recent therapy
* No further evidence-based drug treatment is established, or no satisfactory alternative treatments are available for the locally advanced and/or metastasized carcinoma
* Further therapy is medically feasible
* ECOG (Eastern Cooperative Oncology Group) performance status 0-2
* Life expectancy of at least 12 weeks
* Written informed consent and willingness to cooperate during the course of the study
* Capability to understand the intention and the consequences of the study
Exclusion Criteria:
* Untreated CNS (central nervous system) metastases. Patients with treated CNS metastases are eligible if they are clinically stable with regard to neurologic function
* Pregnant or breast feeding
* Other malignomas, diagnosed \< 5a before inclusion (except localized squamous cell carcinomas of the skin, surgically curable melanomas of the skin, basal cell carcinomas of the skin)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05032092
Study Brief:
Protocol Section:
NCT05032092